DHEA Supplementation Confers No Additional Benefit to that of Growth Hormone on Pregnancy and Live Birth Rates in IVF Patients Categorized as Poor Prognosis.

Keane, Kevin N; Hinchliffe, Peter M; Rowlands, Philip K; Borude, Gayatri; Srinivasan, Shanti; Dhaliwal, Satvinder S; Yovich, John L

Keane, Kevin N; Hinchliffe, Peter M; Rowlands, Philip K; Borude, Gayatri; Srinivasan, Shanti; Dhaliwal, Satvinder S; Yovich, John L.

Afiliação

Keane KN; School of Pharmacy and Biomedical Science, Faculty of Health Sciences, Curtin University, Perth, WA, Australia.
Hinchliffe PM; PIVET Medical Centre, Perth, WA, Australia.
Rowlands PK; PIVET Medical Centre, Perth, WA, Australia.
Borude G; PIVET Medical Centre, Perth, WA, Australia.
Srinivasan S; PIVET Medical Centre, Perth, WA, Australia.
Dhaliwal SS; PIVET Medical Centre, Perth, WA, Australia.
Yovich JL; Faculty of Health Sciences, School of Public Health, Curtin University, Perth, WA, Australia.

Front Endocrinol (Lausanne) ; 9: 14, 2018.

Article em En | MEDLINE | ID: mdl-29445356

Palavras-chave

adjuvants; dehydroepiandrosterone; embryo quality; growth hormone; in vitro fertilization

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Tipo de estudo: Prognostic_studies Idioma: En Revista: Front Endocrinol (Lausanne) Ano de publicação: 2018 Tipo de documento: Article País de afiliação: Austrália

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google